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1. Introduction
   Infections at burn and surgical wounds with Gram-
positive (GP) and Gram-negative (GN) aerobic bacteria have 
become a constant source of consternation to clinicians and 
surgeons. In the last few decades, management of wounds 
and associated co-morbidities has been creating increasing 
levels of failures in their control, because of the emergence 
of multidrug resistant (MDR) bacteria, escalating to other 
body parts as blood stream infections (BSIs). Moreover, the 
decaying part of a burn-wound picks up opportunistic 
infections including fungi even, widening the opportunity 
for super-infection by several bacteria, both from 
community/hospital settings originally unrelated to skin; 
eventually, this leads to bacteremia in several vital organs 
idiosyncratic to type and the extent of drug resistance of the 
infecting bacterium[1]. Bacteria, Staphylococcus aureus (S. 
aureus), Enterococcus faecalis (E. faecalis) and Streptococcus 
pyogenes (S. pyogenes ) , as GPs, and Pseudomonas 
aeruginosa (P. aeruginosa), Klebsiella sp., Escherichia coli 
(E. coli), Proteus sp., Haemophilus sp. and Moraxella sp., 
among GN aerobic bacteria, as well as Bacteroides sp. and 
Fusobacterium sp., as anaerobic ones, are found mainly 
causing suppurations at wound sites, which lead to cystitis, 
otitis, boils, mastitis, phlebitis, meningitis, pneumonia, 
osteomyelitis, endocarditis urinary tract infection (UTI), 
and a few more[2]. Among opportunistic GNs, P. aeruginosa 
especially is the ill-famed notorious pathogen linked to 
doggedly intractable burn injuries[3], promoting urinary 
tract infections (UTIs) even, leading to renal failure or/and 
endocarditis leading to heart failure, due to suppurative 
bacteria with portal entry as BSI[4]. Indeed, extrication from 
Objective: To examine antibiograms of a cohort of suppurative bacteria isolated from wound-
swabs from hospitalized patients of all economic groups of a typical Indian teaching hospital. 
Methods: In surveillance, antibiotic resistance patterns of 10 species of suppurative bacteria 
isolated from wound-swabs over a period of 24 months were recorded. Those were subjected to 
antibiotic sensitivity test, using 16 prescribed antibiotics of 5 different groups (3 aminoglycosides, 
4 beta-lactams, 3 cephalosporins, 4 fluoroquinolones, and 2 stand-alone) in each 6-month 
interval of the study period. Results: Of 1 156 samples collected, 819 samples yielded pathogenic 
bacteria, of which, Staphylococcus aureus (S. aureus), Streptococcus pyogenes (S. pyogenes), 
Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Enterococcus faecalis (E. faecalis), 
Klebsiella pneumoniae (K. pneumoniae), Acinetobacter baumannii (A. baumannii), Enterobacter 
aerogenes (E. aerogenes), Proteus mirabilis (P. mirabilis) and Proteus vulgaris (P. vulgaris) 
were isolated in the order of predominance. Isolated bacterial strains were floridly multidrug 
resistant. Strains of E. faecalis and S. aureus were found resistant to vancomycin, one of the newly 
introduced antibiotics. Conclusions: Of these S. aureus, particularly the methicillin resistant 
strain predominates, followed by strains of S. pyogenes and P. aeruginosa that were in the higher 
proportions of multidrug resistance.
Journal of Acute Disease (2014)148-156
Contents lists available at ScienceDirect
Journal of Acute Disease
journal homepage: www.jadweb.org
149Nabakishore Nayak et al./ Journal of Acute Disease (2014)148-156
the pandemonium of burn injury is a staggering victory, and 
its management looms large to the clinician due to multiple 
infections by MDR bacteria. Specifically, infected surgical 
wounds cause suppurative skin reactions, bacterial fluid 
lesions and subcutaneous nodules leading to metastasis, 
when not properly addressed. An unattended/ unaddressed 
wound-site is the most vulnerable point of entry of the 
marauding pathogen that may cause bacteremia latter 
on, because of its multidrug resistance. Indeed, certain 
GN bacteria (P. aeruginosa, Acinetobacter baumannii (A. 
baumannii), and K. pneumoniae) have emerged with versatile 
strains, resistance to all antibiotics of the present time and 
such strains are informally known as pandrug resistant (PDR) 
bacteria[5,6].
  S. aureus, once known as a harmless commensal of nasal 
nares and soft tissues of the body, has became resistant to 
oxacillin/methicillin (penicillin-derivatives), and is known 
as, methicillin resistant S. aureus (MRSA). In an earlier 
study, IMS and Sum Hospital, Bhubaneswar, had reported 
resistance of MRSA to 23 antibiotics used at the present 
time[7,8], confirming it as the ‘superbug in health domain’, 
in this zone too. Intrinsically, MRSA has become the most 
common suppurative pathogen worldwide today, due to the 
armamentarium of multiple resistances, often creating an 
intractable situation in intensive and critical care units[7-9]. 
From the available literature, it could be spelled out that,
S. aureus has several factors of potential virulence: (1) 
surface proteins promoting colonization in host tissues; 
(2) invasion-promoting proteins causing spread in host 
tissues; (3) surface factors inhibiting phagocytic engulfment 
by host cells of immune system, due to bacterial capsule 
and proteinase-A production; (4) inherent biochemical 
properties such as, catalase production;  (5) immunological 
disguises such as, proteinase-A and coagulase productions 
by bacteria; (6) production of membrane degrading toxins, 
haemotoxin and leukotoxin that modify properties of 
eukaryotic cell membrane; (7) exotoxin production that 
damages host tissues by provoking symptoms of a disease[10]. 
Thus, the majority of diseases caused by S. aureus or MRSA 
and its other recent clonal nexuses are multifactorial. 
Human staphylococcal infections are more frequent, but 
they usually remain at the local entry spot because of 
limited activity of the host defense system at the injury 
spot. A hair follicle, needle-stick injury or a surgical wound 
itself would be common spots of portal entry of a pathogen. 
Staphylococcal pneumonia (S. pneumonia) is the frequent 
complication of pneumonia causing swelling, accumulation 
of pus and additional necrosis of lung-tissue in a more 
serious situation. Moreover, the inflamed area due to
S. aureus is often a fibrin clot of bacteria and dead 
leukocytes, as a pus-filled boil or an abscess[11]. More 
serious infections by S. aureus of skin are furuncles or 
impetigo, and the localized bone infection is osteomyelitis; 
but BSI of S. aureus leads to septicemia and bacteremia 
attacking lungs, kidney, heart, skeletal muscles and 
meninges, at least in old and immunocompromised patients, 
eventually causing utmost morbidity and significant 
mortality[1]. Other suppurative GP bacteria are Streptococcus 
and Enterococcus, which have developed parallel resistance 
to many antibiotics of the time[12]. More often than not, 
multiple bacterial infections are commonplace at injury 
sites. 
  In face of accumulation of a vast majority of literature 
on MDR bacteria, it has become a matter of compulsion to 
conduct a regional surveillance on this exasperating class of 
pathogens, causing morbidity and mortality from general and 
surgical wound sites mainly[13]. This study records a gamut 
of antibiograms using 16 antibiotics of 5 groups of the time, 
with three GP and seven GN bacteria isolated from wound-
swabs of hospitalized patients of a typical Indian tertiary 
care hospital, a systematic study never reported before. This 
study should strengthen the epidemiological database of this 
vast subtropical country and other workers for a comparison 
as well as, in setting the stringent control of infections in a 
hospital. It is anticipated that this work would also benefit 
the pharmacy-world for further strategies in the crusade of 
the control of MDR bacteria, as wound infections give way to 
BSI and many more comorbidities. The infection dynamics 
of each bacterium studied here is so vast in literature that 
they would fill a book or two, when attempts would be made 
to describe their consternation in clinical management. 
This work examines antibiograms of a cohort of suppurative 
bacteria isolated from wound-swabs during 24 months from 
wards and cabins of the hospital, which treats patients of all 
economic groups, from slum dwellers and rural rustics to 
elite mass. 
2. Materials and methods
2.1. Isolation and identification of bacteria
  Strains of three GP, E. faecalis, S. aureus, S. pyogenes, 
and seven GN A. baumannii, E. coli, E. aerogenes, K. 
pneumoniae, P. mirabilis, P. vulgaris, and P. aeruginosa 
were isolated from the in-house patients during the study 
period. The isolated GP and GN bacteria were identified 
basing upon their colony morphology and results obtained 
from standard biochemical test, as done previously[7,14,15]. 
Microbial Type Culture Collection (MTCC) strain of each GP 
or GN bacterium was used as the reference control in each 
biochemical test. 
2.2. Antibiotic susceptibility test
  All bacterial strains including the standard  MTCC  strains 
of each bacterium  were subjected to antibiotic sensitivity 
tests by the Kirby-Bauer’s method/ disc diffusion method, 
using a 4 mm thick Mueller-Hinton (MH) agar (HiMedia, 
Mumbai) medium[16]. An aliquot of 0.1 mL of 0.5 McFarland 
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equivalents, approximately from an exponentially growing 
culture was spread on agar for the development of lawn 
of a strain of a bacterium at 37℃ in a BOD incubator 
(Remi CIM-12S). Further, on the lawn-agar of each plate, 
8 high potency antibiotic discs (HiMedia) of 16 prescribed 
antibiotics of 5 different groups were placed, individually at 
equal distances from one another. Plates were incubated for 
18 h at 37 ℃ and were examined for size-measurements of 
zones of inhibition around each disc, following the standard 
antibiotic susceptibility test chart of Clinical Laboratory 
Standard Institute (CLSI) guidelines[17].  
3. Results
  From hospitalized patients of wards and cabins of IMS 
and Sum Hospital, 1 156 wound-swabs samples yielded 
819 strains of pathogenic bacteria belonging to 10 species 
(three GP and seven GN bacteria) during the span of 24 
months (April 2011- March 2013). All strains (E. faecalis,
S. aureus, S. pyogenes, A. baumannii, E. coli, E. aerogenes, 
K. pneumoniae, P. mirabilis, P. vulgaris and P. aeruginosa) 
were identified by standard biochemical tests and were 
maintained as axenic cultures in suitable media. In total, 
there were 52 strains of E. faecalis, 251 strains of S. aureus, 
210 strains of S. pyogenes, 48 strains of A. baumannii, 39 
Table 1 
Bacteria isolated from wound-swabs of the in-house wards patients.
Bacteria April - September 2011 October 2011- March  2012 April-September 2012 September 2012-March 2013 Total
E. faecalis* 18   7 17 10   52
S. aureus* 61 67 76 47 251
S. pyogenes* 65 59 57 29 210
A. baumannii 12 16 11   9   48 
E. aerogenes 11   6 16   6   39
E. coli 16 18 17 11   62
K. pneumoniae 16 11 19   7   53
P. mirabilis   7   6   7   4   24 
P.  vulgaris   7   4   9   1   21
P. aeruginosa 16 21 14   8   59
Grand total 
(percentage values) 229 (27.96)  215 (26.25) 243 (29.67) 132 (16.11) 819
Note: Total samples collected, 1156; * Gram-positives.
Table 2
Media used for isolation and maintenance pathogenic bacteria from urine samples and their colony characteristics.
Bacterium Standard MTCC strain number Media used Colony characteristics
E. faecalis 439 Blood agar Grey coloured, round, gamma hemolytic colonies
S. aureus 7443 Blood agar Medium to large, smooth, entire, slightly raised, creamy yellow, with green/
beta-hemolytic colonies
Nutrient agar As above without hemolytic activity
S. pyogenes 1928 Blood agar Beta-haemolytic colonies
A. baumannii 1425 Nutrient agar Colourless smooth, opaque,  raised and pinpoint
MacConkey agar Colourless smooth, opaque, raised, NLF 
CLED agar Blue coloured opaque raised NLF 
E. aerogenes 2990 Blood agar White convex with gamma hemolysis
MacConkey agar LF, mucoid
E. coli 443 Nutrient agar Flat dry, irregular
MacConkey agar LF , flat dry pink, irregular
EMB agar Purple coloured, flat dry, irregular colonies, with metallic green colour.
Blood agar Swarms on blood agar with  beta-hemolysis
CLED agar Translucent blue 
K. pneumoniae 4031 MacConkey agar LF, pink, mucoid 
CLED Agar Yellow mucoid
P. mirabilis NA MacConkey agar LLF light pink after 67 h
Blood agar Swarms on blood agar with  beta-hemolysis
CLED agar Translucent blue 
P. vulgaris 1771 Blood agar Swarms on blood agar with beta-hemolysis
CLED agar Translucent blue 
P. aeruginosa 1688 Nutrient agar Large, irregular opaque with bluish green pigment
Note: CLED, Cysteine lactose electrolyte deficient; EMB, Eosin-methylene blue, Lactose fermenting; NLF, Non-lactose fermenting; NA, not 
available.
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strains of E. aerogenes, 62 strains of E. coli, 53 strains of 
K. pneumoniae, 24 strains of P. mirabilis, 21 strains of
P. vulgaris and 59 strains of P. aeruginosa. Thus, S. aureus 
was the maximally isolated suppurative-infection-causing 
bacterium, followed by S. pyogenes, E. coli, P. aeruginosa, 
K. pneumoniae, E. faecalis, A. baumannii, E. aerogenes,
P. mirabilis and P. vulgaris (Table 1). During the last 
6-month period, minimum numbers of pathogens were 
isolated. GP bacteria as medium to large, smooth, entire, 
slightly raised, creamy yellow, green-coloured beta-
haemolytic colonies on blood agar, found positive to catalase 
and coagulase tests were confirmed as S. aureus. Similarly, 
characteristics the rest other GP and GN bacteria are 
presented (Tables 2 and 3).  
  All isolated bacterial strains were subjected to antibiotic 
sensitivity tests with all antibiotics used, in each 6-month 
period. Three aminoglycoside antibiotics (毺g/disc), 
amikacin-30, gentamicin-10 and tobramycin-10 were 
moderately resistant to ten species of pathogens used, in 
ranges, 27% to 76% of 52 strains of E. faecalis, 31% to 79% 
of 251 strains of S. aureus, 51% to 76% of 210 strains of
S. pyogenes, 25% to 71% of 48 strains of A. baumannii, 36% 
to 78% of 39 strains of E. aerogenes, 61% to 81% of 62 strains 
of E. coli, 66% to 79% of 53 strains of  K. pneumoniae, 66% 
to 89%  of 24 strains of P. mirabilis, 61% to 71% of 21 strains 
of  P. vulgaris, 66% to 86% of 59 strains of  P. aeruginosa. 
Among these three antibiotics, amikacin was the most 
resistant antibiotic to these pathogens (Table 4). Mean 
percent values of resistant strains of individual bacteria are 
discernible (Table 4). 
  Similarly, percentages of resistance patterns of 3 GP 
bacteria with four antibiotics of the beta-lactam group are 
detailed (Table 5); resistance patterns were in ranges: 52 to 
74% of 52 strains of E. faecalis, 61 to 82% of 251 strains of
S. aureus, and 47 to 76% of 210 strains of S. pyogenes. 
Likewise, GN bacteria were tested for three beta-lactams 
only with resistance patterns as given: 47% to 77% of 
48 strains of A. baumannii, 52% to 81% of 39 strains of
E. aerogenes, 51% to 89% of 62 strains of E. coli, 54% to 83% 
of 53 strains of K. pneumoniae, 22% to 43% of 24 strains of
P. mirabilis, 34% to 48% of 21 strains of P. vulgaris, 41% 
to 75% of 59 strains of P. aeruginosa. For GN bacteria, 
antibiotics were resistant in the order: ampicillin > 
piperacillin/ tazobactam > amoxyclav. But with GP 
bacteria such an order would be: ampicillin > piperacillin/ 
tazobactam > oxacillin > amoxyclav (Table 5). Mean percent 
Table 3 
Biochemical identifications of isolated Gram-positive and Gram-negative bacteria.
Bacteria Catalase Oxidase Coagulase Indole MR VP Citrate Urease TSI Nitrate Bacitracin Bile esculin
E. faecalis - Nd - Nd Nd Nd Nd Nd Nd Nd - +
S. aureus + Nd + Nd Nd Nd Nd Nd Nd Nd Nd Nd
S. pyogenes + Nd Nd Nd Nd Nd Nd Nd Nd Nd + Nd
A. baumannii + - Nd - - + + V nd - Nd Nd
E. aerogenes + - Nd - - + + - A/A + Nd Nd
E. coli + - Nd + + - - - A/AG + Nd Nd
K. pneumoniae + - Nd - - + + + A/AG + Nd Nd
P. mirabilis + - Nd - + - + + K/A H8S + Nd Nd
P.  vulgaris + - Nd + + - + + K/A H8S + Nd Nd
P. aeruginosa + + Nd - - - + + Nd + Nd Nd
Note: MR, methyl red test; VP, Voges-Proskauer test; TSI, triple sugar iron test; V, variable; A/A, acid in slant and butt; A/AG H2S, acid in slant 
and butt with H2S gas production; A/AG, acid in slant and butt with gas production; K/A H2S, alkali in slant and butt with H2S gas production. 
Nd, not done; +, positive; -, negative
Table 4 
Percentage of resistance of all clinically isolated bacteria to three antibiotics of aminoglycoside group.
Bacterium
Aminoglycosides
Amikacin 30 毺g/disc Gentamicin 10 毺g/disc Tobramycin 10 毺g/disc
I II III IV Mean I II III IV I II III IV Mean
E. faecalis 56 67 76 64 65.75 47 56 59 54 27 34 41 39 35.25
S. aureus 67 76 79 71 73.25 57 59 56 58 31 49 56 54 47.50
S. pyogenes 62 67 76 75 70.00 64 69 73 74 51 55 62 65 58.35
A. baumannii 67 68 71 63 67.25 54 61 63 65 25 31 36 38 31.50
E. aerogenes 66 78 77 73 73.50 48 51 57 68 36 40 41 41 39.50
E. coli 71 76 81 79 76.75 76 79 80 78 61 67 65 69 65.50
K. pneumoniae 66 76 79 79 75.00 67 69 67 66 66 78 77 75 74.00
P. mirabilis 67 69 78 74 72.00 89 67 66 69 87 71 76 75 77.25
P.  vulgaris 66 69 67 70 68.00 69 67 71 70 66 67 61 65 64.75
P. aeruginosa 76 77 76 72 75.25 86 77 67 68 76 68 66 67 69.25
Note: I, April - September 2011; II, October 2011 - March 2012; III, April 2012 - September 2012; IV, November 2012 - March 2013
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values of resistant strains of individual bacteria are evident 
in the Table 5.
  Further, resistance-percent values of suppurative-
infection-causing bacteria to the cephalosporin group 
(cefepime, ceftazidime and ceftriaxone), in three 6-month 
phases were in ranges, 57% to 76% of 52 strains of
E. faecalis, 51% to 76% of 251 strains of S. aureus, 51% to 
85% of 210 strains of S. pyogenes, 45% to 64% of 48 strains 
of A. baumannii, 52% to 72% of 39 strains of E. aerogenes, 
75% to 88% of 62 strains of E. coli, 54% to 74% of 53 strains 
of K. pneumoniae, 32% to 51% of 24 strains of P. mirabilis, 
36% to 46% of 21 strains of  P. vulgaris, 49% to 77% of 59 
strains of P. aeruginosa (Table 6). All these three antibiotics 
were almost equally resistant to the isolated suppurative 
pathogens, confirming the consistence in the production of 
ESBL by majority of isolates. 
  Similarly, resistance-percent values of suppurative 
infect ion causing bacter ia  to  ant ibiot ics  o f  the 
fluoroquinolone group (gatifloxacin, levofloxacin, 
ciprofloxacin and ofloxacin) in three 6-month phases were 
in ranges, 51% to 76% of 52 strains of E. faecalis, 68% to 
89% of 251 strains of S. aureus, 44% to 65% of 210 strains of
S. pyogenes, 45% to 77% of 48 strains of A. baumannii, 47% 
to 81% of 39 strains of E. aerogenes, 60% to 87% of 62 strains 
of E. coli, 58% to 81% of 53 strains of K. pneumoniae, 25% to 
49%  of 24 strains of P. mirabilis, 25% to 45% of 21 strains of 
P. vulgaris, 54% to 81% of 59 strains of P. aeruginosa (Table 
7). These antibiotics were resistant to all these pathogens 
in the order: ofloxacin > gatifloxacin > norfloxacin > 
levofloxacin; the later one was newly introduced.
  Lastly, detailed percentage values of GP bacteria were: 26% 
to 32% of 52 strains of E. faecalis, 36% to 39% of 251 strains 
of S. aureus and 34% to 47% of 210 strains of S. pyogenes for 
linezolid. The resistance patterns of 2 GP bacteria to the 
stand-alone antibiotic, vancomycin were in ranges was in 
ranges, 15% to 19% of 52 strains of E. faecalis, and 11% to 
17% of 251 strains of S. aureus (Table 8). The emergence of 
vancomycin resistant mutants is a matter of clinical concern. 
Of 819 bacterial isolates in this study, S. aureus, S. pyogenes, 
P. aeruginosa, E. faecalis, K. pneumoniae, A. baumannii, 
E. aerogenes and Proteus sp. were found in the order of 
predominance to antibiotic resistance. This study recorded 
that all of these pathogens isolated from clinical samples 
were resistant to all antibiotics individually used. 
Table 5 
Percentage of resistance of all clinically isolated bacteria to four antibiotics of 毬-lactam group.
Bacterium
Beta-lactams
Amoxyclav 30 毺g/disc Ampicillin 10 毺g/disc Oxacillin 1 毺g/disc Piperacillin/tazobactam 100/10 毺g/disc
I II III IV Mean I II III IV Mean I II III IV Mean I II III IV Mean
E. faecalis 62 67 70 74 68.25 52 68 69 72 65.25 59 67 71 72 67.25 53 66 71 69 64.75
S. aureus 71 77 82 79 77.25 68 74 76 77 73.75 66 67 76 74 70.75 61 79 75 78 73.25
S. pyogenes 53 58 61 68 60.00 67 71 76 75 72.25 47 52 56 54 52.25 56 61 65 57 59.75
A. baumannii 55 62 67 65 62.25 69 77 69 59 68.50 - - - - - 47 61 64 55 56.75
E. aerogenes 52 61 72 66 62.75 65 69 75 71 70.00 - - - - - 65 80 81 76 75.50
E. coli 78 82 89 86 83.75 62 71 78 75 71.50 - - - - - 51 57 58 55 55.25
K. pneumoniae 54 67 76 73 67.50 74 79 83 79 78.75 - - - - - 65 72 77 73 71.75
P. mirabilis 25 22 31 35 28.25 32 41 43 39 38.75 - - - - - 27 31 35 35 32.00
P. vulgaris 42 38 41 44 41.25 34 39 48 44 41.25 - - - - - 35 42 44 45 41.50
P. aeruginosa 68 70 75 74 71.75 55 54 67 65 60.25 - - - - - 41 47 51 53 48.00
Note: I, April - September 2011; II, October 2011 - March 2012; III, April 2012 - September 2012; IV, November 2012 - March 2013; -, not 
used.
Table 6 
Percentage of resistance of all clinical isolated bacteria to three antibiotics of cephalosporin group.
Bacterium
Cephalosporins
Cefepime 30 毺g/disc Ceftazidime 30 毺g/disc Ceftriaxone 30 毺g/disc
  I II III IV Mean I II III IV Mean I II III IV Mean
E. faecalis 62 67 70 73 68.00 57 65 76 75 68.25 57 65 67 72 65.25
S. aureus 54 67 76 72 67.25 51 59 62 65 59.25 51 59 62 68 60.00
S. pyogenes 51 57 62 65 58.75 58 79 85 84 76.50 58 79 85 81 75.75
A. baumannii 45 52 57 58 53.00 52 55 61 64 58.00 52 55 59 62 57.00
E. aerogenes 62 70 72 69 68.25 52 57 63 67 59.75 52 57 53 56 54.50
E. coli 75 82 88 86 82.75 79 79 88 87 83.25 79 79 78 76 78.00
K. pneumoniae 64 65 71 74 68.50 54 59 63 61 59.25 54 59 63 60 59.00
P. mirabilis 35 32 36 39 35.50 34 43 45 49 42.75 34 43 45 51 43.25
P. vulgaris 45 38 44 45 43.00 36 41 43 46 41.50 36 41 43 45 41.25
P. aeruginosa 65 71 77 77 72.50 49 61 68 65 60.75 49 61 68 69 61.75
Note: I, April - September 2011; II, October 2011 - March 2012; III, April 2012 - September 2012; IV, November 2012 - March 2013.
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Figure 1. Colonies of S. pyogenes on blood agar. 
4. Discussion
  Surgical wound-sites are generally taken care of 
suitably, as those wounds are planned, but burn injuries 
create beleaguered conditions in hospitals. Burn wounds, 
occurring impromptu, promote multiple infections due to 
the damage of the skin, the physical barrier, and cause 
immune suppression, independently[18]. Wounds being the 
invasive site for staphylococci, streptococci and enterococci 
among GPs, and GNs including pugnacious/PDR strains 
of Acinetobacter, Klebsiella, Pseudomonas and a few more 
genera, are a priory, the prominent reckless nosocomial 
pathogens. Moreover, the ominous A. baumannii in wounds 
is the most rife or notorious peripatetic, etiological agent in 
hospital acquired infections[19]; it is a PDR pathogen[5,14,20], 
affording much difficulty for its control.   
  For the control of wounds, topical antibacterial agents 
are used in addition to systemic ones. The popular topical 
antimicrobial, Acticoat with the silver sulfadiazine 
influences the respiratory chain at the cytochrome level, by 
disrupting the microbial electron transport system mediated 
by the silver ion[21]. In fact, because of the slow release of 
silver ions from Acticoat, a stronger and longer antimicrobial 
effect had been recorded, compared to the other classical 
silver containing topical agents. Thus, it was found as the 
more effective agent against aerobic, anaerobic GPs and 
GNs, fungi, and viruses on wound sites[21]. Another broad 
spectrum topical antibiotic obtained from Pseudomonas 
fluorescens, mupirocin had been recorded strongly inhibiting 
protein and RNA synthesis in pathogens[22]. Moreover, A. 
baumannii in burn injury infections causes delay in the 
wound healing process, probably due to its ability to cause 
systemic circulation; sepsis mostly occurs ending with 
high mortality rates with patients who were inadequately 
treated[20,23]. Acticoat, however, was independently reported 
to control MDR A. baumannii, in vivo by other workers[18,24]. 
Octanidiene dihyrocholride is another topical antibacterial 
agent used in the control of active and chronic wounds[23,25] 
Table 7   
Percentage of resistance of all clinical isolated bacteria to four antibiotics of fluoroquinolone group.
Bacterium
Fluoroquinolones
Gatifloxacin 5 毺g/disc Levofloxacin 5 毺g/disc Ciprofloxacin 5 毺g/disc Ofloxacin 5 毺g/disc
I II III IV Mean I II III IV Mean I II III IV Mean I II III IV Mean
E. faecalis 63 66 72 69 67.50 53 67 69 68 64.25 51 57 69 67 61.00 67 65 76 73 70.25
S. aureus 71 77 82 76 76.50 68 74 76 72 72.50 78 84 89 74 81.25 68 79 85 81 78.25
S. pyogenes 55 57 65 62 59.75 44 49 53 56 50.50 47 52 51 49 49.75 51 59 62 60 58.00
A. baumannii 48 54 59 59 55.00 69 77 59 54 64.75 45 52 61 77 58.75 62 67 74 71 68.50
E. aerogenes 47 52 51 57 51.75 65 69 75 74 70.75 72 78 81 69 75.00 52 61 63 59 58.75
E. coli 75 80 85 78 79.50 60 71 75 74 70.00 75 80 87 71 78.25 74 78 79 75 76.50
K. pneumoniae 58 62 70 68 64.50 74 79 81 80 78.50 63 71 73 79 71.50 60 68 72 72 68.00
P. mirabilis 25 31 29 33 29.50 37 45 46 43 42.75 35 38 45 45 40.75 31 45 47 49 43.00
P. vulgaris 32 38 41 45 39.00 34 39 42 41 39.00 25 34 37 39 33.75 35 37 43 41 39.00
P. aeruginosa 68 72 75 67 70.50 54 54 60 63 57.75 56 59 61 54 57.50 79 81 78 81 79.75
Note: I, April - September 2011; II, October 2011 - March 2012; III, April 2012 - September 2012; IV, November 2012 - March 2013.
Table 8 
Percentage of resistance of all clinical isolated Gram-positive bacteria to two stand-alone antibiotics.
Bacterium
Stand-alone antibiotics
Linezolid 30 毺g/disc Vancomycin 30 毺g/disc
I II III IV Mean I II III IV Mean
E. faecalis 26 28 31 32 29.25 18 19 17 15 17.25
S. aureus 38 36 39 37 37.50 17 11 14 12 13.50
S. pyogenes 34 45 47 42 42.00 - - - - -
Note: I, April - September 2011; II, October 2011 - March 2012; III, April 2012 - September 2012; IV, November 2012 - March 2013; -, not 
used. For Gram- negatives, these two antibiotics are not used.
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without any disadvantage of the other chemical, silver 
sulfadiazine, as the later has a lower escher-penetration 
rate, needing frequent applications, whereas octenidine 
dihydrochloride based formulations are effective against 
GPs, GNs and fungi[26]. Quintessentially, Acticoat had 
appreciable control actions over octanidiene dihyrocholride 
or chlorhexidine acetate on A. baumannii[23]. Sofra-tulle 
(framycetin sulphate bp 1%), framyzyne are sulfamylone 
creams, also are used as topical applications for burn 
injuries with Pseudomonas infections. Indeed, aggressive 
uses of antibiotics lead to conditions for the growth of fungi 
in burns; Candida albicans is the most common associated 
fungal pathogen[27]. Powdered sulfonamides, as well as, 
its cream-based formulations had been a popular topical 
medicine for burn wounds, with a limited absorption 
of sulfonamides at injured sites. Further, in children, 
agranulocytes are induced with another control agent, 
sulfapyridine, when applied to burn injuries. Therefore, 
sulfonamide creams are rarely used for burn injuries. 
Nevertheless, sulfadyazine are less readily absorbed in the 
body in comparison to sulfonamides[28].
  GP bacteria particularly survive the thermals of burning, 
unless an immediate topical treatment is done around 48 
hours; staphylococci come up from the sweat glands and 
hair follicles colonizing at the burn site[29].  In a typical 
study, from surgical wounds analyzed with 343 patients,
S. aureus was prevalent at 28.2%, P. aeruginosa at 25.32%, 
E. coli at 7.8%, S. epidermidis at 7.1% and E. faecalis at 
5.6%[30]. Proteus sp. particularly was reported to have been 
isolated from an Indian tertiary care hospital; all the isolated 
strains of pathogens were resistant to the entire antibiotics 
group used, among which, S. aureus in GPs, A. baumannii 
and P. aeruginosa among GNs had the maximum resistance 
values[31].  In a study from Netherlands, it was reported that 
a cohort of 11 patients and nurses of the surgical ward of 
a hospital were infected with S. pyogenes with a particular 
serotype of low virulence; another group of patients from 
the same hospital had infection with another serotype of 
S. pyogenes causing heavy delay in wound healing[32]. This 
study clearly demonstrated the outbreak of S. pyogenes 
infections in hospital settings. 
  Apart from surgical wounds, post-operative peritonitis is 
an important determinant in toxic shock syndrome in ICU 
patients. In a study from Paris, it was found that GP bacteria 
were prevalent in 40% of cases and E. faecium was the 
leading organism (19%), followed by streptococci (11%), S. 
aureus (3%), coagulase negative staphylococci (8%). Similarly, 
among infections from GNs, Enterobacteriaceae members 
contribute 37% of the total infection; E. coli were 18%, and 
the rest other bacteria were as follows: Enterobacter 8%, 
Klebsiella 5%, Morganella 3%, Proteus 2%, Citrobacter 2%; 
Pseudomonas 6% and A. baumannii 1%. The prevalence 
of the total anaerobic bacteria causing post-operative 
peritonitis in this study was 13% with the predominance of 
Bacteroides sp. Among all these bacteria, the prevalence of 
MDR Enterobacteriaceae was 5% and that of P. aeruginosa 
was 2%[33]. An Indian study, however, recorded increasing 
incidences of MDR Klebsiella sp., isolated from 72% 
infected hospitalized patients, out of which, 3.44% isolates 
were capable of the production of Klebsiella pneumoniae 
carbapenemase enzyme, of which 26 strains from hospital 
and 8 strains were from community isolates[34]. From Greece, 
MDR GN bacteria were reported from ICU surgical patients; 
it was reported that hospitalization for more than 5 days 
increased the susceptibility towards MDR infections[13]. 
Sternal wound infections after cardiac surgery were caused 
by MRSA and GNs in 22.4%, within two years of study with 
1895 patients in France[35]. It is consensus that a patient 
admitted to a hospital, more often with resource-limited 
settings, for a specific problem or even due to problems 
of old age, picks up one or more MDR infectious bacteria. 
Risk-factors of post-discharge invasive infection from MRSA 
in hospitalized patients can be imagined, as monitored with 
MRSA in the USA through BSI for its high rates of antibiotic 
resistance, for example[36].
  It is believed that antibiotics are symbol and substance 
of clinical management today, and it is hard to think of 
an aspect of contemporary life that does not depend on 
antibiotics. Taking to surprise, nosocomial spread of MDR 
bacteria has become so commonplace that clinicians of both 
developing and developed countries get often emotionally 
grueled during treatment to delirious hospitalized patients of 
any ailment, with whom an infection on hospitalization with 
an MDR bacterium could be a terminal illness. As known, 
several factors contribute to the problem of the emergence of 
MDR bacteria: (1) Device-and-fomite-associated nosocomial 
infections are frequent in hospital settings everywhere and 
always[37], with begrimed settings. (2) The drug resistance 
character has ramifications: bacteria may be resistance to 
representative, frequently used antibiotics of several classes; 
paradigmatically, the production of extended spectrum 
毬-lactamase has rendered resistance to antibiotics 
of penicillin/cephalosporin group[38]; carbapenemase 
production affords resistance in GN bacteria to carbapenems 
(imipenem, meropenem and ertapenem) in use. (3) Mutation 
rates in bacteria are faster because of simple, plastic 
genomes — one mutant cell in 106 to 108 bacterial cells 
in the presence of an antibiotic-stress is known to be drug 
resistant[39]. (4) To avoid host toxicity, antibiotics doses 
are mostly fixed at some lower concentration that is often 
below the mutant preventive concentration [40], giving ways 
to the development of mutants. (5) Genetic recombination 
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mechanisms (bacterial transformation and conjugation) are 
operative in natural systems, such as hospital sewages, 
facilitating the creation of a pool of drug resistant characters 
in camaraderie MDR strains[41]. (6) Absence of a stringent 
antibiotic policy triggers the emergence of resistant bacteria 
as both clinicians and patients use antibiotics belonging 
to higher generations without often being warranted. (7) 
Patients, particularly, often do not complete the course of 
prescribed dose of an antibiotic, because of the blithesome 
effect of the control of infection from the start of the course. 
Thus, bacterial resistance to antibiotics is a consistently 
complex and dynamic affair, involving major genetic 
and biochemical mechanisms, bacterial transformations, 
interchange of integrons, hypermutabilty, plasmids mediated 
improvements in resistance factors, ending with drug 
efflux mechanism and gaining of characters to synthesize 
indigenous and exogenous antibiotic degrading enzymes. 
  This study demonstrated that most of these pathogens 
isolated from clinical samples were MDR and they are 
potential enough to destroy the clinical totem pole of a 
hospital and to precipitate devastating episodes in the 
community. As analyzed, suppurative infections are one of 
the major problems of health, as MDR bacteria could attack 
several organs such as lungs, heart and kidneys, through 
BSI. Compared to infection studies on suppurative pathogens 
from other hospitals globally, the surveillance data of this 
typical hospital clearly gives high values of wound infections 
among which, the MRSA infection predominates. Burn 
injuries are needed to be attended more stringently in this 
peninsula too. Steps to prevent invasive infections of most 
of these pathogens, particularly MRSA in communities must 
be started in the hospital with proper/ prior post-discharge 
settings.
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